Back to search

Article

Cys128 of AP1G1 is a new target for drug development in inhibiting viruses entry to host respiratory mucosal cell

2025-04-04

Abstract excerpt

\fancypagestyle firstpage\fancyhf \lhead \chead \rhead \cfoot فروردین ماه ۱۴۰۴ Background and Purpose:Itaconate has been proven to play a role in infectious diseases by interacting with target proteins through Michael addition. In this study, we reveal that itaconate can reduce virus invasion by inhibiting host endocytosis on virus particle, which greatly enhances host defense against respiratory infections. Thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3bba7d23-e2ed-513e-b344-f2232bba2d90
DOI
10.22541/au.174376458.84458625/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cys128 of AP1G1 is a new target for drug development in inhibiting viruses entry to host respiratory mucosal cellDOI 10.22541/au.174376458.84458625/v1
Select a neighboring publication to make it the new centre.